ARA: Una injecció reverteix símptomesde l’Alzheimer en ratolins
L’administració de nanopartícules permet netejar toxines del cervell
Search Results for:
EL PERIÓDICO: Científicos de BCN y China revierten el alzhéimer en ratones
Diseñan una novedosa técnica centrada en restaurar la salud vascular con inyecciones de nanopartículas. «En una hora se han empezado a ver resultados».
Scientists reverse Alzheimer’s in mice using nanoparticles
An international team co-led by the Institute for Bioengineering of Catalonia (IBEC) and the West China Hospital Sichuan University (WCHSU) was able to reverse Alzheimer’s in mice after only 3 injections with nanoparticles. The innovative approach to treating the disease focuses on restoring the normal function of the vasculature, rather than acting on neurons or other brain cells, as has usually been done until now. This achievement, published in the Signal Transduction and Targeted Therapy Journal, is a promising step towards an effective treatment for Alzheimer’s disease.
New York Post: Alzheimer’s breakthrough? Scientists use nanotech to reverse disease in mice
A new study reveals innovative nanotechnology that restored the function of the blood-brain barrier (BBB) to reverse Alzheimer’s in mice.
The Telegraph: Alzheimer’s reversed in mice under breakthrough treatment
Injection of nanoparticles “reminds” blood-brain barrier to work properly, allowing brain cells to communicate again
IBEC and IQS host the 2nd Barcelona Blood-Brain Barrier Conference
The event, jointly organised by the Institute for Bioengineering of Catalonia (IBEC) and the Institut Químic de Sarrià (IQS), brought together leading scientists from around the world to discuss the latest advances in blood-brain barrier (BBB) research, from its fundamental biology to its role in disease and therapeutic strategies.
LA VANGUARDIA: ¿Cómo mejorar el desarrollo de fármacos que lleguen al cerebro?
El IBEC diseña un chip que simula la barrera hematoencefálica.
IBEC and SEMIT host the first SEMIT Congress in Barcelona
The Institute for Bioengineering of Catalonia (IBEC) and the Spanish Society of Regenerative Medicine and Tissue Engineering (SEMIT) organized the inaugural SEMIT 2025 Congress. The event gathered leading national and international experts in regenerative medicine and tissue engineering, creating a unique platform for knowledge exchange among researchers, clinicians, and industry.
